Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase in... Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.2 | -7.02576112412 | 17.08 | 17.3499 | 14.11 | 1291992 | 15.70968287 | CS |
| 4 | 6.71 | 73.173391494 | 9.17 | 18.38 | 8.685 | 2034954 | 14.68795281 | CS |
| 12 | 3.09 | 24.1594996091 | 12.79 | 18.38 | 8.241 | 933168 | 13.62605133 | CS |
| 26 | 4.07 | 34.4623200677 | 11.81 | 18.38 | 8.241 | 523198 | 13.5362045 | CS |
| 52 | 2.97 | 23.0054221534 | 12.91 | 18.38 | 8.241 | 344518 | 13.25386297 | CS |
| 156 | -5.22 | -24.7393364929 | 21.1 | 21.98 | 5.85 | 262133 | 13.19429322 | CS |
| 260 | -5.22 | -24.7393364929 | 21.1 | 21.98 | 5.85 | 262133 | 13.19429322 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
